Teva Pharmaceutical Industries reported $1.23B in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Aspen Pharmacare ZAR 6.06B 867M Jun/2024
Cipla INR 17.78B 2.41B Jun/2025
Dr.Reddys Laboratories INR 21.74B 989M Jun/2025
Guangzhou Baiy 2.33B 2.63B Mar/2025
Jiangsu Hengrui 2.98B 890.87M Jun/2025
Kalbe Farma IDR 1.3T 18.7B Jun/2025
Richter Gedeon HUF 75.72B 6.71B Sep/2024
Sh Fosun Pharma 1.69B 17.13M Jun/2025
Sun Pharmaceuticals INR 39.48B 5.23B Jun/2025
Teva Pharmaceutical Industries USD 1.23B 124M Jun/2025